X0708 D/A LIVE 0001553643 RELMADA THERAPEUTICS, INC. 880 3RD AVENUE, 12TH FLOOR NEW YORK NY NEW YORK 10022 646 876 3459 NEVADA Camp Nine, Inc. CAMP NINE, INC. Corporation true Sergio Traversa 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Director CEO Charles Casamento 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Chairman of the Board Paul Kelly 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Maged Shenouda 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Director Ottavio Vitolo 880 Third Avenue 12th Floor New York NY NEW YORK 10022 Executive Officer Chief Medical Officer Biotechnology No Revenues 06b true 0001213900-19-011648 2019-06-14 false true true false 10000 Alexander Capital, LP 40077 None None 17 STATE STREET 5TH FLOOR NEW YORK NY NEW YORK 10004 AL ALABAMA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS IN INDIANA KY KENTUCKY MD MARYLAND MA MASSACHUSETTS MN MINNESOTA NJ NEW JERSEY NY NEW YORK OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TX TEXAS false Brookline Capital Markets, A division of Arcadia Securities, LLC 44656 None None 509 MADISON AVENUE, SUITE 906 NEW YORK NY NEW YORK 10022 AL ALABAMA AK ALASKA AZ ARIZONA CA CALIFORNIA CO COLORADO GA GEORGIA MD MARYLAND MI MICHIGAN MS MISSISSIPPI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OH OHIO PA PENNSYLVANIA TX TEXAS WY WYOMING false 10000000 8432437 1567563 false 116 688887 0 Alexander Capital and Brookline received a cash fee (excluding expenses) of $518,687 and $170,200, respectively, and warrants to purchase an aggregate of 427,817 shares of common stock. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false RELMADA THERAPEUTICS, INC. /s/ Sergio Traversa Sergio Traversa CEO 2019-07-10